Ali Kocabaş

1.5k total citations
32 papers, 819 citations indexed

About

Ali Kocabaş is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Ali Kocabaş has authored 32 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 6 papers in Surgery. Recurrent topics in Ali Kocabaş's work include Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Respiratory Support and Mechanisms (4 papers). Ali Kocabaş is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Respiratory Support and Mechanisms (4 papers). Ali Kocabaş collaborates with scholars based in Türkiye, United States and Canada. Ali Kocabaş's co-authors include William M. Vollmer, A. Sonia Buist, Peter Burney, İsmail Hanta, Wan C. Tan, Paul Enright, Amund Gulsvik, David M. Mannino, Mary Ann McBurnie and Anamika Jithoo and has published in prestigious journals such as European Respiratory Journal, Thorax and Cancer Letters.

In The Last Decade

Ali Kocabaş

32 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Kocabaş Türkiye 14 569 283 93 89 76 32 819
Sebastian T. Lugg United Kingdom 11 452 0.8× 232 0.8× 166 1.8× 97 1.1× 91 1.2× 29 1.0k
R. Escamilla France 18 779 1.4× 430 1.5× 59 0.6× 36 0.4× 222 2.9× 62 1.1k
SF Paul Man Canada 11 416 0.7× 239 0.8× 39 0.4× 43 0.5× 60 0.8× 15 606
Mette Thomsen Denmark 8 534 0.9× 292 1.0× 154 1.7× 39 0.4× 113 1.5× 14 980
Sharon R Rosenberg United States 11 453 0.8× 115 0.4× 29 0.3× 51 0.6× 72 0.9× 18 715
E Huhti Finland 20 598 1.1× 391 1.4× 97 1.0× 222 2.5× 165 2.2× 59 1.2k
Juan Luis Rodríguez Hermosa Spain 20 1.0k 1.8× 444 1.6× 45 0.5× 22 0.2× 118 1.6× 90 1.3k
Yong Suk Jo South Korea 16 406 0.7× 151 0.5× 41 0.4× 51 0.6× 97 1.3× 60 582
James P. Allinson United Kingdom 11 663 1.2× 313 1.1× 30 0.3× 62 0.7× 93 1.2× 36 801
A. Cavaillès France 10 574 1.0× 174 0.6× 91 1.0× 25 0.3× 78 1.0× 16 689

Countries citing papers authored by Ali Kocabaş

Since Specialization
Citations

This map shows the geographic impact of Ali Kocabaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Kocabaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Kocabaş more than expected).

Fields of papers citing papers by Ali Kocabaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Kocabaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Kocabaş. The network helps show where Ali Kocabaş may publish in the future.

Co-authorship network of co-authors of Ali Kocabaş

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Kocabaş. A scholar is included among the top collaborators of Ali Kocabaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Kocabaş. Ali Kocabaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özyılmaz, Ezgi, Emine Kılıç Bağır, Leman Sencar, et al.. (2018). Early propranolol treatment amelioratesendothelial dysfunction in experimental septic lung. Advances in Clinical and Experimental Medicine. 28(3). 291–297. 5 indexed citations
2.
Köktürk, Nurdan, Alev Gürgün, Elif Şen, et al.. (2017). The View of the Turkish Thoracic Society on the Report of the GOLD 2017 Global Strategy for the Diagnosis, Management, and Prevention of COPD. Turkish Thoracic Journal. 18(2). 57–64. 20 indexed citations
3.
Kocabaş, Ali, et al.. (2014). The effect of Vitamin D deficiency on lung function in current smoker COPD patients. European Respiratory Journal. 44(Suppl 58). P945–P945. 2 indexed citations
4.
Burney, Peter, Anamika Jithoo, Bernet Kato, et al.. (2013). Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty—a BOLD analysis. Thorax. 69(5). 465–473. 160 indexed citations
5.
Özyılmaz, Ezgi, et al.. (2012). Endobronchial capillary hemangioma: a very rare cause of massive hemoptysis. Tuberkuloz ve Toraks. 60(1). 78–80. 2 indexed citations
6.
Mannino, David M., Mary Ann McBurnie, Wan C. Tan, et al.. (2012). Restricted spirometry in the Burden of Lung Disease Study.. PubMed. 16(10). 1405–11. 72 indexed citations
7.
Hooper, Richard, Peter Burney, William M. Vollmer, et al.. (2011). Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. European Respiratory Journal. 39(6). 1343–1353. 79 indexed citations
8.
Vollmer, William M., Peter Burney, Paul Enright, et al.. (2009). Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. European Respiratory Journal. 34(3). 588–597. 188 indexed citations
9.
Hanta, İsmail, et al.. (2008). The effect of different treatment modalities on oxidative stress in COPD. Advances in Therapy. 25(7). 710–717. 13 indexed citations
10.
Hanta, İsmail, et al.. (2008). The evaluation of latent tuberculosis in rheumatologic diseases for anti-TNF therapy: experience with 192 patients. Clinical Rheumatology. 27(9). 1083–1086. 29 indexed citations
11.
Hanta, İsmail, et al.. (2007). Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFα. Clinical Rheumatology. 26(11). 1867–1870. 15 indexed citations
12.
Hanta, İsmail, et al.. (2006). Oxidant–Antioxidant Balance in Patients with COPD. Lung. 184(2). 51–55. 45 indexed citations
13.
Hanta, İsmail, et al.. (2004). A Rare Case of Hurthle Cell Carcinoma with Endobronchial Metastasis. Endocrine Journal. 51(2). 155–157. 5 indexed citations
14.
Hanta, İsmail, et al.. (2003). The Oxidant-Antioxidant Balance in Mild Asthmatic Patients. Lung. 181(6). 347–352. 18 indexed citations
15.
Gümürdülü, Derya, Philip T. Cagle, Fazi̇let Kayaselçuk, et al.. (2002). Specificity of MOC-31 and HBME-1 immunohistochemistry in the differential diagnosis of adenocarcinoma and malignant mesothelioma: a study on environmental malignant mesothelioma cases from Turkish villages. Pathology & Oncology Research. 8(3). 188–193. 15 indexed citations
16.
17.
Kocabaş, Ali, et al.. (1997). Combination of chemotherapy and recombinant interferon-alpha in advanced non-small cell lung cancer. Cancer Letters. 112(1). 17–22. 4 indexed citations
18.
Kocabaş, Ali, et al.. (1996). Value of preoperative spirometry to predict postoperative pulmonary complications. Respiratory Medicine. 90(1). 25–33. 45 indexed citations
19.
Kalyoncu, Alı Fuat, et al.. (1995). Survey of the allergic status of patients with bronchial asthma in Turkey: a multicenter study. Allergy. 50(5). 451–455. 28 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastian T. Lugg Breakdown of academic impact, for papers by R. Escamilla Breakdown of academic impact, for papers by SF Paul Man Breakdown of academic impact, for papers by Mette Thomsen Breakdown of academic impact, for papers by Sharon R Rosenberg Breakdown of academic impact, for papers by E Huhti Breakdown of academic impact, for papers by Juan Luis Rodríguez Hermosa Breakdown of academic impact, for papers by Yong Suk Jo Breakdown of academic impact, for papers by James P. Allinson Breakdown of academic impact, for papers by A. Cavaillès
Rankless by CCL
2026